The Future of Gene Patents and the Implications for Medicine

173 JAMA Internal Medicine 1569, Sept. 2013

2 Pages Posted: 15 Sep 2013 Last revised: 25 Sep 2013

Jacob S. Sherkow

New York Law School

Henry T. Greely

Stanford Law School

Date Written: September 23, 2013

Abstract

The Supreme Court decision in Myriad Genetics struck down the patenting of human genomic DNA. What will this mean for genetic testing and medicine, more broadly?

Keywords: gene, genetic, patent, intellectual property, myriad, amp, medicine, BRCA, cancer

JEL Classification: K00, K11, O3, O34

Suggested Citation

Sherkow, Jacob S. and Greely, Henry T., The Future of Gene Patents and the Implications for Medicine (September 23, 2013). 173 JAMA Internal Medicine 1569, Sept. 2013. Available at SSRN: https://ssrn.com/abstract=2325679

Jacob S. Sherkow (Contact Author)

New York Law School ( email )

185 West Broadway
New York, NY 10013
United States
212.431.2355 (Phone)

HOME PAGE: http://www.nyls.edu/faculty/faculty-profiles/faculty_profiles/jacob-s-sherkow/

Henry (Hank) T. Greely

Stanford Law School ( email )

559 Nathan Abbott Way
Stanford, CA 94305-8610
United States
650-723-2517 (Phone)
650-725-0253 (Fax)

Paper statistics

Downloads
166
Rank
146,733
Abstract Views
615